Lumbosacral spinal stenosis. Spinal stenosis, lumbar region
Conditions
Interventions
Intervention 1: Intervention group: Injection of 18 cc Ozone-Oxygen mixture (2% _98%) at a concentration of 20 µg / dl at six points (three cc in each point) in the paravertebral muscles at 2 cm from
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Back pain and other symptoms of spinal canal stenosis in the last six months Age between 35_75 years Confirmation of spinal canal stenosis through MRI and EDX
Exclusion criteria
Exclusion criteria: Diabetes Melitus Rheumatologic and collagen vascular diseases peripheral neuropathy and nerve injury Brucellosis BMI more than 41 History of trauma and spinal fracture Bleeding disorder Allergic reaction to Bovin protein Genetic disease such as Galactose intolerance or Lactase deficiency Patient with cardiac problem Inability to communicate and complete the questionnaire History of liver ,kidney and cardiopulmonary problem History of periarticular or intraarticular in the past 6 months Pregnant women People with cancer People taking Anticoagulant Favism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score according to Visual Analog Scale. Timepoint: At baseline (before intervention), 2, 4 and 8 weeks after injection. Method of measurement: Visual Analog Scale.;Patient Performance Score in Oswestry Disability Scale. Timepoint: At baseline (before intervention), 2, 4 and 8 weeks after injection. Method of measurement: Oswestry Low Back Pain Questionnaire.;Patient Performance Score in QUEBEC Back Pain Disability. Timepoint: At baseline (before intervention), 2, 4 and 8 weeks after injection. Method of measurement: QUEBEC Back Pain Disability Qestionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhane Parvin
Shiraz University of Medical Sciences
Outcome results
None listed